Insights into mitotic checkpoint by integrating CRISPR and RNAi
Our recent study of the mitotic checkpoint protein BUB1 (budding uninhibited by benzimidazoles 1) revealed several apparent BUB1 knock-out cell lines expressing low levels of BUB1 protein sufficient to support spindle assembly checkpoint activity. This rings alarm bells on the application of CRISPR...
| 出版年: | Molecular & Cellular Oncology |
|---|---|
| 第一著者: | |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Taylor & Francis Group
2019-07-01
|
| 主題: | |
| オンライン･アクセス: | http://dx.doi.org/10.1080/23723556.2019.1603436 |